Chips · Stock report · Unimicron (TWSE: 3037.TW)
Unimicron — new 52-week high, yet only 20th of 85 chip stocks over one month
The Closelooknet read
Unimicron (TWSE: 3037.TW) set a new 52-week closing high of TWD 1,215.00 on 1 October, yet it is not the leader of our chip section: its 21.6% one-month gain ranks 20th of the 85 stocks in our chip section. Our money-flow reading (a gauge of net buying pressure) is 204.5, still positive but slowing, down 38.1 over the past month. Our composite score is 59 of 100, with momentum at 97 and valuation at 33. What we watch: whether the close stays above the prior high of TWD 1,185.00 set on 24 September, or slips back under it while money flow keeps slowing.
Where Unimicron stands among our chip stocks
Unimicron's 21.6% one-month move is 20th of 85 in our chip section. Among the peers we track across venues, Intel (INTC) rose 34.9% over the month and AT&S (ATS.VI) 33.8%, ahead of Unimicron. Ibiden (4062.T) gained 18.9%, Corning (GLW) 10.2% and AGC Inc. (5201.T) 1.0%, behind it. On distance from the high, Unimicron is at its high while Ibiden is 9.2% below its June peak, Intel 14.9%, AT&S 15.5%, AGC 29.6% and Corning 37.3%.
Our money-flow and quality readings
Our money-flow reading is 204.5 and labelled warm: still positive but slowing, down 6.4 over five sessions and 38.1 over the past month. Momentum scores 97 of 100, growth 65 and balance sheet 64. Capital allocation scores 57, cash quality 43, valuation 33 and quality 33. The Piotroski score, a check of financial health, is scored 7 of 9. The composite stands at 59.
Price trend
Unimicron closed at TWD 1,215.00, up 3.4% on the day and 8.5% over five sessions. It is up 452.3% this year and 723.7% over twelve months. It trades 21.9% above its 50-day average of TWD 997.06 and 72.5% above its 200-day average of TWD 704.52, the average close of the last 200 sessions. Its typical daily swing is about 5.1%. A stochastic signal turned down from overbought in late September, a sign momentum is cooling.
Closelooknet is a research diary. Nothing here is investment advice or a recommendation to buy or sell.